Bukeyan Miao

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer”.

Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer

Journal of Medicinal Chemistry(2021)10.1021/acs.jmedchem.1c00900

N/A

0DataRank · unranked

142 citations

Lijie Zhao, Xin Han, Chong Qin, Bukeyan Miao, Donna McEachern +10 more

Strategies toward Discovery of Potent and Orally Bioavailable Proteolysis Targeting Chimera Degraders of Androgen Receptor for the Treatment of Prostate Cancer

Journal of Medicinal Chemistry(2021)10.1021/acs.jmedchem.1c00882

N/A

0DataRank · unranked

139 citations

Lijie Zhao, Weiguo Xiang, Chong Qin, Bukeyan Miao, Donna McEachern +8 more

Discovery of ARD-2051 as a Potent and Orally Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.3c00405

N/A

0DataRank · unranked

58 citations

Lijie Zhao, Weiguo Xiang, Bukeyan Miao, Chong Qin, Mi Wang +16 more